Description

Dyslexia is a learning disability in reading. People with dyslexia have trouble reading at a good pace and without mistakes. They may also have a hard time with reading comprehension, spelling, and writing. The global dyslexia market is poised to grow by US$ 10.8 billion from 2022 to 2028, registering a CAGR of 6.7% during the forecast period, according to StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for dyslexia. The global dyslexia market is segmented on the basis of category, type of dyslexia, end user, and region. By category, the global dyslexia market has been segmented into treatment, diagnosis. The treatment segment was the largest contributor to the global dyslexia market in 2021. Based upon type of dyslexia, the global dyslexia market is categorized into phonological dyslexia, surface dyslexia, others. According to the research, the phonological dyslexia segment had the largest share in the global dyslexia market. On the basis of end user, the global dyslexia market has been segmented into specialty centers, home care, hospitals & clinics, others. In terms of geography, the global dyslexia market has been segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The global dyslexia market is highly competitive. The key players in the dyslexia market include Eli Lilly and Company, GSK plc, Lingit AS, Lyfta Oy, Novartis AG, Pfizer Inc., Soli, Speechify Inc., Teva Pharmaceutical Industries Ltd.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the dyslexia market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Category: treatment, diagnosis
Type of dyslexia: phonological dyslexia, surface dyslexia, others
End user: specialty centers, home care, hospitals & clinics, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global dyslexia market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Dyslexia market overview
Part 3. Market breakdown by category
– Treatment
– Diagnosis
Part 4. Market breakdown by type of dyslexia
– Phonological dyslexia
– Surface dyslexia
– Others
Part 5. Market breakdown by end user
– Specialty centers
– Home care
– Hospitals & clinics
– Others
Part 6. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 7. Key companies
– Eli Lilly and Company
– GSK plc
– Lingit AS
– Lyfta Oy
– Novartis AG
– Pfizer Inc.
– Soli
– Speechify Inc.
– Teva Pharmaceutical Industries Ltd.
About StrategyHelix
Disclaimer